UNSPSC 51373338: Hydrocodone/ibuprofen

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373338 Hydrocodone/ibuprofen is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, products outside the hydrocodone/ibuprofen category entirely. The mismatch suggests either a classification error in the source data or that state and local procurement offices are applying this code to opioid-related harm-reduction supplies rather than the combination analgesic itself. State and local buyers under this code, when present, appear to include county health departments and community health agencies focused on public health initiatives rather than traditional pharmaceutical distribution chains.

Seminole County, Florida represents the only recent documented activity. The county issued an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023—though this date appears inconsistent with the posting date and may reflect a data entry error. The procurement requires electronic bid submission through the county's e-Procurement Portal, includes E-Verify and drug-free workplace certification, and carries a two-year initial term with a one-year renewal option. Beyond this single Seminole County solicitation, the code shows no supporting recent state or local opportunities that would allow characterization of broader geographic spread or a pattern of issuing bodies.